pharmecons easy access ltd
pharmecons easy access ltd Company Information
Company Number
10872912
Next Accounts
Sep 2025
Industry
Research and experimental development on biotechnology
Research and experimental development on social sciences and humanities
Shareholders
magdalini afroditi chatzikou
Group Structure
View All
Contact
Registered Address
63-65 heworth road, york, YO31 0AA
Website
pharmecons.compharmecons easy access ltd Estimated Valuation
Pomanda estimates the enterprise value of PHARMECONS EASY ACCESS LTD at £125.1k based on a Turnover of £97.3k and 1.29x industry multiple (adjusted for size and gross margin).
pharmecons easy access ltd Estimated Valuation
Pomanda estimates the enterprise value of PHARMECONS EASY ACCESS LTD at £0 based on an EBITDA of £-116.7k and a 6.15x industry multiple (adjusted for size and gross margin).
pharmecons easy access ltd Estimated Valuation
Pomanda estimates the enterprise value of PHARMECONS EASY ACCESS LTD at £1.1k based on Net Assets of £602 and 1.9x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Pharmecons Easy Access Ltd Overview
Pharmecons Easy Access Ltd is a live company located in york, YO31 0AA with a Companies House number of 10872912. It operates in the research and experimental development on social sciences and humanities sector, SIC Code 72200. Founded in July 2017, it's largest shareholder is magdalini afroditi chatzikou with a 100% stake. Pharmecons Easy Access Ltd is a young, micro sized company, Pomanda has estimated its turnover at £97.3k with declining growth in recent years.
Upgrade for unlimited company reports & a free credit check
Pharmecons Easy Access Ltd Health Check
Pomanda's financial health check has awarded Pharmecons Easy Access Ltd a 1.5 rating. We use a traffic light system to show it exceeds the industry average on 1 measures and has 7 areas for improvement. Company Health Check FAQs
1 Strong
2 Regular
7 Weak
Size
annual sales of £97.3k, make it smaller than the average company (£3.3m)
- Pharmecons Easy Access Ltd
£3.3m - Industry AVG
Growth
3 year (CAGR) sales growth of -17%, show it is growing at a slower rate (9.3%)
- Pharmecons Easy Access Ltd
9.3% - Industry AVG
Production
with a gross margin of 51.6%, this company has a comparable cost of product (51.6%)
- Pharmecons Easy Access Ltd
51.6% - Industry AVG
Profitability
an operating margin of -120% make it less profitable than the average company (0.8%)
- Pharmecons Easy Access Ltd
0.8% - Industry AVG
Employees
with 1 employees, this is below the industry average (37)
1 - Pharmecons Easy Access Ltd
37 - Industry AVG
Pay Structure
on an average salary of £66.2k, the company has an equivalent pay structure (£66.2k)
- Pharmecons Easy Access Ltd
£66.2k - Industry AVG
Efficiency
resulting in sales per employee of £97.3k, this is less efficient (£116.6k)
- Pharmecons Easy Access Ltd
£116.6k - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- Pharmecons Easy Access Ltd
- - Industry AVG
Creditor Days
its suppliers are paid after 7 days, this is quicker than average (48 days)
- Pharmecons Easy Access Ltd
48 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Pharmecons Easy Access Ltd
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 65 weeks, this is more cash available to meet short term requirements (46 weeks)
65 weeks - Pharmecons Easy Access Ltd
46 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 77.2%, this is a higher level of debt than the average (44.6%)
77.2% - Pharmecons Easy Access Ltd
44.6% - Industry AVG
PHARMECONS EASY ACCESS LTD financials
Pharmecons Easy Access Ltd's latest turnover from December 2023 is estimated at £97.3 thousand and the company has net assets of £602. According to their latest financial statements, Pharmecons Easy Access Ltd has 1 employee and maintains cash reserves of £2.6 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | |
|---|---|---|---|---|---|---|
| Turnover | ||||||
| Other Income Or Grants | ||||||
| Cost Of Sales | ||||||
| Gross Profit | ||||||
| Admin Expenses | ||||||
| Operating Profit | ||||||
| Interest Payable | ||||||
| Interest Receivable | ||||||
| Pre-Tax Profit | ||||||
| Tax | ||||||
| Profit After Tax | ||||||
| Dividends Paid | ||||||
| Retained Profit | ||||||
| Employee Costs | ||||||
| Number Of Employees | 1 | 2 | 2 | 1 | ||
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | |
|---|---|---|---|---|---|---|
| Tangible Assets | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Debtors | 0 | 0 | 40,325 | 47,050 | 53,312 | 63,791 |
| Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 |
| Misc Debtors | 79 | 135 | 594 | 223 | 321 | 72 |
| Cash | 2,559 | 142,981 | 155,304 | 68,349 | 137,158 | 68,474 |
| misc current assets | 0 | 0 | 0 | 0 | 0 | 0 |
| total current assets | 2,638 | 143,116 | 196,223 | 115,622 | 190,791 | 132,337 |
| total assets | 2,638 | 143,116 | 196,223 | 115,622 | 190,791 | 132,337 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 996 | 996 | 1,196 | 1,195 | 1,174 | 905 |
| Group/Directors Accounts | 1,040 | 2,130 | 3,750 | 2,710 | 331 | 509 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 0 | 26,459 | 190,543 | 97,830 | 62,356 | 25,427 |
| total current liabilities | 2,036 | 29,585 | 195,489 | 101,735 | 63,861 | 26,841 |
| loans | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 0 | 0 | 0 | 0 | 0 | 0 |
| provisions | 0 | 0 | 0 | 0 | 0 | 0 |
| total long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 |
| total liabilities | 2,036 | 29,585 | 195,489 | 101,735 | 63,861 | 26,841 |
| net assets | 602 | 113,531 | 734 | 13,887 | 126,930 | 105,496 |
| total shareholders funds | 602 | 113,531 | 734 | 13,887 | 126,930 | 105,496 |
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | |
|---|---|---|---|---|---|---|
| Operating Activities | ||||||
| Operating Profit | ||||||
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 |
| Amortisation | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax | ||||||
| Stock | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors | -56 | -40,784 | -6,354 | -6,360 | -10,230 | 63,863 |
| Creditors | 0 | -200 | 1 | 21 | 269 | 905 |
| Accruals and Deferred Income | -26,459 | -164,084 | 92,713 | 35,474 | 36,929 | 25,427 |
| Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash flow from operations | ||||||
| Investing Activities | ||||||
| capital expenditure | ||||||
| Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 |
| cash flow from investments | ||||||
| Financing Activities | ||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | -1,090 | -1,620 | 1,040 | 2,379 | -178 | 509 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | 0 | 0 | 0 | 0 | 0 | 0 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 |
| share issue | ||||||
| interest | ||||||
| cash flow from financing | ||||||
| cash and cash equivalents | ||||||
| cash | -140,422 | -12,323 | 86,955 | -68,809 | 68,684 | 68,474 |
| overdraft | 0 | 0 | 0 | 0 | 0 | 0 |
| change in cash | -140,422 | -12,323 | 86,955 | -68,809 | 68,684 | 68,474 |
pharmecons easy access ltd Credit Report and Business Information
Pharmecons Easy Access Ltd Competitor Analysis
Perform a competitor analysis for pharmecons easy access ltd by selecting its closest rivals, whether from the PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES sector, other micro companies, companies in YO31 area or any other competitors across 12 key performance metrics.
pharmecons easy access ltd Ownership
PHARMECONS EASY ACCESS LTD group structure
Pharmecons Easy Access Ltd has no subsidiary companies.
Ultimate parent company
PHARMECONS EASY ACCESS LTD
10872912
pharmecons easy access ltd directors
Pharmecons Easy Access Ltd currently has 2 directors. The longest serving directors include Dr Michael Kerr (Jul 2018) and Dr Magdalini Chatzikou (Oct 2024).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Dr Michael Kerr | United Kingdom | 57 years | Jul 2018 | - | Director |
| Dr Magdalini Chatzikou | United Kingdom | 47 years | Oct 2024 | - | Director |
P&L
December 2023turnover
97.3k
-50%
operating profit
-116.7k
0%
gross margin
51.6%
-4.87%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2023net assets
602
-0.99%
total assets
2.6k
-0.98%
cash
2.6k
-0.98%
net assets
Total assets minus all liabilities
pharmecons easy access ltd company details
company number
10872912
Type
Private limited with Share Capital
industry
72190 - Other research and experimental development on natural sciences and engineering
72110 - Research and experimental development on biotechnology
72200 - Research and experimental development on social sciences and humanities
incorporation date
July 2017
age
8
incorporated
UK
ultimate parent company
accounts
Total Exemption Full
last accounts submitted
December 2023
previous names
N/A
accountant
TAXASSIST ACCOUNTANTS
auditor
-
address
63-65 heworth road, york, YO31 0AA
Bank
-
Legal Advisor
-
pharmecons easy access ltd Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to pharmecons easy access ltd.
pharmecons easy access ltd Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for PHARMECONS EASY ACCESS LTD. This can take several minutes, an email will notify you when this has completed.
pharmecons easy access ltd Companies House Filings - See Documents
| date | description | view/download |
|---|
